COVID-19 | Singapore to stop covering healthcare costs for patients who refuse to get vaccinated

The Singapore authorities have announced that as of December 8 they will stop covering the medical expenses of COVID-19 for patients who refuse to be vaccinated, except for those who cannot do so for medical reasons or due to age.

SIGHT: Prolonged COVID-19 | “75% of the cases had a very mild infection”

“Currently, unvaccinated people make up a large proportion of those who require intensive care and contribute disproportionately to the ”, indicated the Ministry of Health on its website.

In the last three weeks, infections in the city-state have stabilized at around 3,000 a day, of which 99% of cases are mild or have no symptoms thanks to a tof the population.

SIGHT: The EMA evaluates the possible use of Moderna’s vaccine in children aged 6 to 11 years

However, the authorities fear that an increase in infections could be caused by intensive care units, which are already at 70% of their capacity.

To increase the vaccination rate, authorities are studying the rates of children between the ages of 5 and 11.

SIGHT: COVID-19 | The EMA analyzes molnupiravir to authorize its emergency use

Last month, the authorities announced that workers who have not been vaccinated against COVID-19 or have not had the disease recently will have to present a

Despite the fact that the Government has lifted most of the restrictions, there are still limitations such as the number of people allowed in restaurants and public events, while increasing the number of countries from where you can travel to the city-state without need to quarantine.

Singapore, one of the countries that best and before reacted to the COVID-19 pandemic with strict measures and the closure of borders, given the difficulty of eliminating the virus, especially due to the contagious delta variant.

Since the start of the pandemic, Singaporean authorities have detected 221,000 COVID-19 infections and 511 deaths, most of them since last August.

• COVID-19 | The EMA analyzes molnupiravir to authorize its emergency use
• The EMA evaluates the possible use of Moderna’s vaccine in children aged 6 to 11 years
• Monoclonal antibodies reduced the risk of COVID-19 by 80% for at least 8 months
• “75% of patients who are in rehabilitation for prolonged covid had a very mild infection”
• The pandemic generated eight million tons of plastic waste that will end up in rivers and oceans
• Vaccine doubles antibodies in patients who had mild COVID-19
• COVID-19 | On vaccines, ventilation and other measures that do work in the pandemic
• Question of the day: what should we know about COVID-19 pills?
• COVID-19 | Why Europe is (again) the epicenter of the pandemic, according to WHO
• COVID-19 | Experts call for a “thorough examination” before vaccinating children under 12 years of age
• COVID-19 | Dogs and cats can become infected and suffer from heart problems
• How does the Pfizer pill that reduces the 89% risk of death from COVID-19 work?
• Lab accused of making mistakes during Pfizer vaccine trials
• COVID-19 | Russian EpiVacCorona Vaccine Has Similar Efficacy To Sputnik V, Creators Say
• How does molnupiravir, the first approved pill against COVID-19, work?
• COVID-19 | WHO clarifies that vaccines do not affect fertility or cause impotence

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn